Mind Medicine (MindMed) Inc.

DB:MMQ Stock Report

Market Cap: €529.2m

Mind Medicine (MindMed) Management

Management criteria checks 3/4

Mind Medicine (MindMed)'s CEO is Rob Barrow, appointed in Jun 2021, has a tenure of 3.42 years. total yearly compensation is $2.14M, comprised of 27.9% salary and 72.1% bonuses, including company stock and options. directly owns 0.27% of the company’s shares, worth €1.45M. The average tenure of the management team and the board of directors is 2.3 years and 3.1 years respectively.

Key information

Rob Barrow

Chief executive officer

US$2.1m

Total compensation

CEO salary percentage27.9%
CEO tenure3.4yrs
CEO ownership0.3%
Management average tenure2.3yrs
Board average tenure3.1yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Rob Barrow's remuneration changed compared to Mind Medicine (MindMed)'s earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$98m

Jun 30 2024n/an/a

-US$102m

Mar 31 2024n/an/a

-US$125m

Dec 31 2023US$2mUS$599k

-US$96m

Sep 30 2023n/an/a

-US$77m

Jun 30 2023n/an/a

-US$75m

Mar 31 2023n/an/a

-US$63m

Dec 31 2022US$5mUS$672k

-US$57m

Sep 30 2022n/an/a

-US$69m

Jun 30 2022n/an/a

-US$69m

Mar 31 2022n/an/a

-US$98m

Dec 31 2021US$12mUS$350k

-US$93m

Compensation vs Market: Rob's total compensation ($USD2.14M) is above average for companies of similar size in the German market ($USD1.03M).

Compensation vs Earnings: Rob's compensation has been consistent with company performance over the past year.


CEO

Rob Barrow (35 yo)

3.4yrs

Tenure

US$2,143,133

Compensation

Mr. Robert Barrow, also known as Rob, serves as Chief Executive Officer at Mind Medicine (MindMed) Inc since June 9, 2021 and serves a its Director since December 13, 2021. He served as Chief Development O...


Leadership Team

NamePositionTenureCompensationOwnership
Robert Barrow
CEO & Director3.4yrsUS$2.14m0.27%
€ 1.5m
Daniel Karlin
Chief Medical Officer3.8yrsUS$1.04m0.32%
€ 1.7m
Miriam Wernli
Executive President4.3yrsUS$2.66m0.16%
€ 844.2k
Scott Freeman
Co-Founder & Clinical Advisorno dataUS$501.19kno data
Leonard Latchman
Co-founderno datano datano data
Carrie Liao
VP & Chief Accounting Officer2yrsno data0.060%
€ 319.4k
Mark Sullivan
Chief Legal Officer & Corporate Secretary1.6yrsno data0.072%
€ 380.4k
Francois Lilienthal
Chief Commercial Officer2.6yrsno datano data
Stephanie Fagan
Chief Corporate Affairs Officerless than a yearno datano data
Gregg Pratt
Chief Regulatory & Quality Assurance Officerno datano datano data

2.3yrs

Average Tenure

55.5yo

Average Age

Experienced Management: MMQ's management team is considered experienced (2.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Robert Barrow
CEO & Director2.9yrsUS$2.14m0.27%
€ 1.5m
Carol Vallone
Independent Chairperson3.2yrsUS$196.20k0.018%
€ 94.7k
David Gryska
Independent Director1.4yrsUS$179.01k0.011%
€ 58.6k
Suzanne Bruhn
Independent Director2.3yrsUS$148.70k0.017%
€ 88.3k
Robert Malenka
Chair of Scientific Advisory Board3.7yrsno datano data
Robert Dworkin
Member of Scientific Advisory Board3.3yrsno datano data
Maurizio Fava
Member of Scientific Advisory Board3.4yrsno datano data
Andreas Krebs
Independent Vice Chairman3.2yrsUS$186.20k0.016%
€ 84.3k
Roger Crystal
Independent Director2.3yrsUS$148.70k0.017%
€ 88.3k
Nzinga Harrison
Member of Scientific Advisory Boardless than a yearno datano data
Peter Bergethon
Member of Scientific Advisory Board3.4yrsno datano data
Maria Oquendo
Member of Scientific Advisory Board3yrsno datano data

3.1yrs

Average Tenure

63.5yo

Average Age

Experienced Board: MMQ's board of directors are considered experienced (3.1 years average tenure).